HOPE KANSIIME
ID: UNCST-2024-R004499
|
Designing an optimised framework for effective usage and efficient access of Electronic resources in the consortium of Ugandan university libraries
REFNo: SIR561ES
To establish the acceptability and usability of the developed framework designed to enhance the access and usage of e –resources within the consortium of Uganda university libraries,To design and develop an optimised framework aimed at improving the accessibility and utilization of e-resources within the consortium of Uganda university libraries,To determine the necessary prerequisites for creating an optimized framework that will improve the accessibility and utilization of e-resources in the consortium of Uganda university libraries?,To conduct a cross-sectional study to evaluate how E-resources are utilised, examine access patterns and identify barriers and challenges to their usage within the consortium of Uganda university libraries,To optimise Electronic resource utilisation in Ugandan university consortium by developing an efficient access and usage framework,
|
Uganda |
2025-11-04 13:31:17 |
2028-11-04 |
Engineering and Technology |
Non-Clinical Trial |
Degree Award |
|
Edwin Nuwagira
ID: UNCST-2021-R013488
|
Improving Diagnostic Strategies for Post-Tuberculosis Lung Disease in Ugandan Primary Health Care Settings (IMPULSE-TB)
REFNo: HS6402ES
To test the feasibility and acceptability of the diagnostic algorithm in facilitating timely post-TB lung diseasediagnosis at primary healthcare facilities,To use qualitative methods to identify barriers and facilitators of diagnosis to post-TB lung disease,To develop, test and validate a clinical algorithm for diagnosing post-TB lung disease based on clinical and sociodemographic characteristics,
|
Uganda |
2025-11-04 13:29:51 |
2028-11-04 |
Medical and Health Sciences |
|
Non-degree Award |
|
Francis Pebalo Pebolo
ID: UNCST-2022-R010630
|
Incidence, risk factors and clinical outcomes of neonatal sepsis among HIV-exposed infants of mothers on dolutegravir-based antiretroviral therapy in Uganda
REFNo: HS6486ES
Comparing 28-day clinical outcomes of mothers with HIV on DTG-based ART compared with their HIV negative counterparts.,To compare 28-day clinical outcomes among HIV-exposed neonates of mothers on DTG-based ART and HIV-unexposed neonates.,To compare sepsis incidence risk factors among HIV-exposed neonates of mothers on DTG-based ART and HIV-unexposed neonates,To conduct a scoping review to describe the epidemiology of neonatal sepsis of neonates born to mothers with HIV comparing outcomes on DTG- and non-DTG-containing regimens,
|
Uganda |
2025-11-04 13:00:07 |
2028-11-04 |
Medical and Health Sciences |
|
Degree Award |
|
ERIC WOBUDEYA
ID: UNCST-2019-R001047
|
Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV
REFNo: HS6555ES
Primary Objectives
Cohort 1 and Cohort 2
• To determine the weight-band dosing of RPT taken as part of the 1HP regimen by evaluating:
⎯ PK RPT exposures among children with and without HIV
⎯ Safety and tolerability of the 1HP regimen among children with HIV while receiving twice-daily DTG and children without HIV through 28 days of dosing
Cohort 2
• To evaluate the effect of RPT taken as part of the 1HP regimen on the PK of DTG
Secondary Objectives
Cohort 1 and Cohort 2
• To evaluate the effect of covariates including age, weight, sex, ethnicity, nutritional status, and HIV-1 status on the PK of RPT taken as part of the 1HP regimen
• To evaluate the safety of the 1HP regimen through 24 weeks of follow-up
• To evaluate the palatability and acceptability of the 1HP regimen
• To evaluate adherence to the 1HP regimen
Cohort 2
• To evaluate the safety and tolerability of twice-daily DTG through 42 days among children with HIV who are receiving 1HP
• To evaluate virologic control (less than 200 copies/mL) at Day 42 among children taking a DTG-based ARV treatment regimen co-administered with 1HP
|
Uganda |
2025-11-04 12:59:17 |
2028-11-04 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Isaac Ssewanyana
ID: UNCST-2020-R014336
|
ConfiSign HIV/Syphilis Combo Self-Test: Evaluation of Clinical Performance and Usability in the hands of untrained users.
REFNo: HS6687ES
Untrained users will either take part in the label comprehension study and results interpretation study (part A) or in the observed untrained user study (part B). Untrained users enrolled for the label comprehension and results interpretation study (part A), shall not participate in the observed user study (part B) and vice versa.,The primary and overall objective of this study is to evaluate the performance and the usability of the ConfiSign HIV/Syphilis Combo Self-Test in the hands of untrained users from a low prevalence HIV region (< 5%) who have no, or limited experience in self-testing. ,
|
Uganda |
2025-10-29 16:22:26 |
2028-10-29 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|